Summary
- Current Price
- As of today, PODD price is $145.13, up +1.20% on
- Current Price All-Time High
- PODD price is currently -59.10% below its historical high of $354.88 set on
- Market Cap
- PODD current market cap is $10B, down -57.64% year-over-year
- PE Ratio
- PODD current PE ratio is 28.77
- Revenue
- PODD current annual revenue is $2.71B, up +30.73% year-over-year
- Next Earnings
- The next earnings release for PODD is on
Profile
| Metric | Value |
|---|---|
| Full Name | Insulet Corporation |
| Ticker | NASDAQ: PODD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | |
| Website | insulet.com |
| Employees | 3,900 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $145.13 | |
| Price, 1D Change | +1.20% | |
| Market Cap | $10B | |
| - | ||
| PE Ratio | 28.77 | |
| Beta | 0.26 | |
| Revenue | $2.71B | |
| Revenue, 1Y Change | +30.73% | |
| EPS | $3.48 | |
| EPS, 1Y Change | -39.85% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $3.48 | |
| EPS Estimate | $6.50 | N/A |
| EPS Est. Change | +86.91% | N/A |
| Revenue | $2.71B | |
| Revenue Estimate | $3.29B | N/A |
| Revenue Est. Change | +21.40% | N/A |
| Current Price | $145.13 | |
| Price Target | $167.50 | - |
| Price Tgt. Change | +15.41% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.21 | $5.78 | +79.94% | |
| $4.89 | $3.48 | -28.83% | |
| $6.50 | N/A | +86.91% | |
| $7.71 | N/A | +121.63% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.05B | $2.07B | +0.81% | |
| $2.69B | $2.71B | +0.62% | |
| $3.29B | N/A | +21.40% | |
| $3.74B | N/A | +38.26% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -57.01% | |
| Price, 3Y | -19.91% | |
| Market Cap, 1Y | -57.64% | |
| Market Cap, 3Y | -20.43% | |
| Revenue, 1Y | +30.73% | |
| Revenue, 3Y | +107.47% | |
| EPS, 1Y | -39.85% | |
| EPS, 3Y | +5,187.39% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $145.13 | |
| SMA 200 | $214.77 | |
| SMA 50 | $154.08 | |
| EMA 200 | $199.98 | |
| EMA 50 | $153.65 | |
| MACD | -$3.22 | |
| Beta | 0.26 | |
| ATR | $6.24 | |
| 14-Day RSI | 45.15 | |
| 10-Day Volatility | 42.65% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $2.71B | |
| EPS | $3.48 | |
| Gross Profit | $1.94B | |
| Gross Margin | 72.17% | |
| Operating Income | $473.80M | |
| Operating Margin | 17.50% | |
| Net Income | $247.10M | |
| Net Margin | 9.12% | |
| EBITDA | $564.20M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.66 | |
| 2.78 | ||
| 2.15 | ||
| - | ||
| 9 | ||
| 5.52 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 28.77 | |
| 3.30 | ||
| 7.08 | ||
| 16.38 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $1.52B | |
| $716.10M | ||
| $3.19B | ||
| $1.91B | ||
| $1.68B | ||
| $680.10M | ||
| Total Debt | $1.00B | |
| $22.20M | ||
| $75.00M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $2.46B | ||
| $1.47B | ||
| $753.70M | ||
| $0.00 | ||
| $90.40M | ||
| $0.00 | ||
| $92.40M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $569.30M | ||
| -$222.70M | ||
| -$595.30M | ||
| Capex | $219.40M | |
| $349.90M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wells Fargo | → | |
| UBS | → | |
| Truist Securities | → | |
| TD Cowen | → | |
| Stifel | → | |
| RBC Capital | → | |
| Leerink Partners | → | |
| JP Morgan | → | |
| Canaccord Genuity | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
No data
Screeners with PODD
FAQ
- What is the ticker symbol for Insulet Corporation?
- The ticker symbol for Insulet Corporation is NASDAQ:PODD
- Does Insulet Corporation pay dividends?
- No, Insulet Corporation does not pay dividends
- What sector is Insulet Corporation in?
- Insulet Corporation is in the Healthcare sector
- What industry is Insulet Corporation in?
- Insulet Corporation is in the Medical Devices industry
- What country is Insulet Corporation based in?
- Insulet Corporation is headquartered in United States
- When did Insulet Corporation go public?
- Insulet Corporation initial public offering (IPO) was on May 15, 2007
- Is Insulet Corporation in the S&P 500?
- Yes, Insulet Corporation is included in the S&P 500 index
- Is Insulet Corporation in the NASDAQ 100?
- No, Insulet Corporation is not included in the NASDAQ 100 index
- Is Insulet Corporation in the Dow Jones?
- No, Insulet Corporation is not included in the Dow Jones index
- When was Insulet Corporation last earnings report?
- Insulet Corporation's most recent earnings report was on August 5, 2026
- When does Insulet Corporation report earnings?
- The next expected earnings date for Insulet Corporation is November 5, 2026
Data Sources & References
- PODD Official Website www.insulet.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1145197/000114519726000028/0001145197-26-000028-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- PODD Profile on Yahoo Finance finance.yahoo.com/quote/PODD
- PODD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/podd